Adrenergic receptors in premenstrual dysphoric disorder. II. Neutrophil β2-adrenergic receptors: G(s) protein coupling, phase of menstrual cycle and prediction of luteal phase symptom severity

Psychiatry Research

Volumn 79, Issue 1, 1998, Pages 31-42

  Gurguis, George N M ^a   Yonkers, Kimberly A ^b   Blakeley, Jaishri E ^a   Phan, Stephanie P ^b   Williams, Anita ^b   Rush, A John ^b  

^a VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Anxiety; Coupling; Depression; G(s) protein; Premenstrual syndrome; 2 Adrenergic receptors

Indexed keywords

ANTIDEPRESSANT AGENT; BETA 2 ADRENERGIC RECEPTOR; ESTRADIOL; GUANINE NUCLEOTIDE BINDING PROTEIN; ISOPRENALINE; MONOAMINE OXIDASE INHIBITOR; PROGESTERONE; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DYSPHORIA; FEMALE; FOLLICULAR PHASE; HORMONAL THERAPY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUTEAL PHASE; MENSTRUAL CYCLE; NEUTROPHIL; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR DENSITY;

EID: 0032474583     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(98)00025-0     Document Type: Article

References (56)

1. Aitken R.C.B. Measurement of feelings using visual analogue scales. Proceedings of the Royal Society of London, Series B: Biological Science. 62:1969;989-993.
2. Albus M., Bondy B., Ackenheil M. Adrenergic receptors on blood cells: relationship to the patho-physiology of anxiety. Clinical Neuropharmacology. 9(Suppl 4):1986;359-361.
3. American Psychiatric Association, 1994. Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Press, Washington, D.C.
4. Biegon A., Reches A., Snyder L., McEwen B.S. Serotonergic and noradrenergic receptors in the rat brain: modulation by chronic exposure to ovarian hormones. Life Sciences. 32:1983;2015-2021.
5. Bloch M., Schmidt P.J., Rubinow D.R. Premenstrual syndrome: evidence for symptom stability across cycles. American Journal of Psychiatry. 154:1997;1741-1746.
6. Carstens M.E., Engelbrecht A.H., Russell V.A., Aalbers C., Gagiano C.A., Chalton D.O., Taljaard J.J.F. Beta-adrenoceptors on lymphocytes of patients with major depressive disorder. Psychiatry Research. 20:1987;239-248.
7. 3 cells. Endocrinology. 121:1987;1711-1715.
8. 2-Adrenergic receptors in hamster smooth muscle cells are transcriptionally regulated by glucocorticoids. Journal of Biological Chemistry. 263:1988;9067-9070.
9. Davies A.O., Lefkowitz R.J. Corticosteroid-induced differential regulation of β-adrenergic receptors in circulating human polymorphnuclear leukocytes and mono-nuclear leukocytes. Journal of Clinical Endocrinology and Metabolism. 51:1980;599-605.
10. Endicott, J., Harrison, W. The Daily Record of Severity of Problems. Available from Dr. Endicott, New York State Psychiatric Institute, Biometrics Unit, 722 West 168th Street, New York, NY 10032.
11. Endicott J., Nee J., Cohen J., Halbreich U. The premenstrual changes: patterns and correlates of daily ratings. Journal of Affective Disorders. 10:1986;127-135.
12. First, M.B., Spitzer, R.L., Gibbon, M., Williams, J.B.W. Structured Clinical Interview for Axis I DSM-IV Disorders - Patient Edition (SCID-I/P, version 2.0), Biometrics Research Dept., NY State Psychiatric Institute, 722 West 168th Street, New York, NY 10032. ©1994 Biometrics Research Dept.
13. Fishman P.H., Finberg J.P.M. Effect of the tricyclic antidepressant desipramine on β-adrenergic receptors in cultured rat glioma C6 cells. Journal of Neurochemistry. 49:1987;282-289.
14. Folstein M.F., Luria R. Reliability, validity, and clinical application of the visual analogue mood scale. Psychological Medicine. 3:1973;479-486.
15. Foster P.S., Goldie R.G., Patterson J.W. Effect of steroids on β-adrenoceptor-mediated relaxation of pig bronchus. British Journal of Pharmacology. 78:1983;441-445.
16. s protein in panic disorder. Abstract #448. Biological Psychiatry. 35:1994;739.
17. Hadcock J.R., Malbon C.C. Agonist regulation of gene expression of adrenergic receptors and G proteins. Journal of Neurochemistry. 60:1993;1-9.
18. Halper J.P., Brown R.P., Sweeney J.A., Kocsis J.H., Peters A., Mann J.J. Blunted β-adrenergic responsivity of peripheral blood mononuclear cells in endogenous depression. Archives of General Psychiatry. 45:1988;241-244.
19. Hamilton M. The assessment of anxiety states by rating. British Journal of Medical Psychology. 32:1959;50-55.
20. Hamilton M. Development of a rating scale for primary depressive illness. British Journal of the Society of Clinical Psychology. 6:1967;278-296.
21. Hancock A.A., Marsh C.L. Agonist interactions with β-adrenergic receptors following chronic administration of desipramine or the atypical antidepressants, iprindole and mianserin. Journal of Receptor Research. 5:1985;311-334.
22. Harrison W., Sandberg D., Gorman J., Fyer M., Nee J., Uy J., Endicott J. Provocation of panic with carbon dioxide inhalation in patients with premenstrual dysphoria. Psychiatry Research. 27:1989;183-192.
23. Hatjis C.G., Koritnid D.R., Crews A. Up-regulation of guinea pig myometrial β-adrenoreceptors by systemic estradiol and progesterone. Endocrinology. 122:1988;1455-1459.
24. 2- and β-adrenoceptor function induced by repeated administration of desipramine or electroconvulsive shock. Neuropharmacology. 27:1988;1151-1159.
25. Lefkowitz R.J., Hausdorff W.P., Caron M.G. Role of phosphorylation in desensitization of the β-adrenoceptor. Trends in Pharmacological Sciences. 11:1990;190-194.
26. Lowry O.H., Rosenbrough N.J., Farr A.L., Randall R.J. Protein measurement with Folin phenol reagent. Journal of Biological Chemistry. 193:1951;265-275.
27. Luria R.E. The validity and reliability of the visual analogue mood scale. Journal of Psychiatric Research. 12:1975;51-57.
28. Maggi A., Zucchi I., Perez J. Progesterone in rat brain: modulation of β-adrenergic receptor activity. Pharmacological Research Communications. 17:1985;283-291.
29. Magliozzi J.R., Gietzen D., Maddock R.J., Haack D., Doran A.R., Goodman T., Weiler P.G. Lymphocyte beta-adrenoreceptor density in patients with unipolar depression and normal controls. Biological Psychiatry. 26:1989;15-25.
30. 2-adrenergic receptor gene are obligate for glucocorticoid regulation of receptor mRNA levels. Biochemical and Biophysical Research Communications. 154:1988;676-681.
31. Manier D.H., Gillespie D.D., Sulser F. 5,7-Dihydroxytryptamine-induced lesions of serotonergic neurons and desipramine-induced down-regulation of cortical beta adrenoceptors: a re-evaluation. Biochemical Pharmacology. 19:1987;3308-3310.
32. Marone G., Lichtenstein L.M., Plaut M. Hydrocortisone and human lymphocytes: increases in cyclic adenosine 3′:5′-monophosphate and potentiation of adenylate cyclase-activating agents. Journal of Pharmacology and Experimental Therapeutics. 215:1980;469-478.
33. Mazzola-Pomietto P., Azorin J., Tramoni V., Jeanningros R. Relation between lymphocyte beta adrenergic responsivity and the severity of depressive disorders. Biological Psychiatry. 35:1994;920-925.
34. Munson P.J., Rodbard D. LIGAND: a versatile computerized approach for characterization of ligand binding systems. Analytical Biochemistry. 197:1983;220-239.
35. Munson, P.J., Rodbard, D., 1984. Computerized analysis of ligand binding data: basic principles and recent development. In: Rodbard, D., Fortig (Eds.), Computers in Endocrinology. Raven Press, New York, pp. 117-145.
36. Newman M.E., Lerer B. Post-receptor-mediated increases in adenylate cyclase activity after chronic antidepressant treatment: relationship to receptor desensitization. European Journal of Pharmacology. 162:1989;345-352.
37. 2-responses to intravenous salbutamol during the menstrual cycle. European Journal of Clinical Pharmacology. 46:1994;511-515.
38. Okada F., Tokumitsu Y., Ui M. Desensitization of beta-adrenergic receptor-coupled adenylate cyclase in cerebral cortex after in vivo treatment of rats with desipramine. Journal of Neurochemistry. 47:1986;454-459.
39. Pandey G.N., Janicak P.G., Davis J.M. Decreased beta-adrenergic receptors in the leukocytes of depressed patients. Psychiatry Research. 22:1987;265-273.
40. Pandey G.N., Pandey S.C., Davis J.M. Peripheral adrenergic receptors in affective illness and schizophrenia. Pharmacology and Toxicology. 66:1990;13-36.
41. Perkins J.P., Su Y., Harden T.K. Adaptive changes in the responsiveness of adenylate cyclase to catecholamines. Drug and Alcohol Dependence. 4:1979;279-294.
42. 2-Adrenergic receptors and receptor coupling to adenylate cyclase in human mononuclear leukocytes and platelets in relation to physiological variations of sex steroids. Journal of Clinical Endocrinology and Metabolism. 58:1984;1068-1076.
43. Sandberg D., Endicott J., Harrison W., Nee J., Gorman J. Sodium lactate infusion in late luteal phase dysphoric disorder. Psychiatry Research. 46:1993;79-88.
44. 2-Adrenoceptor density during menstrual cycle and pregnancy, in delivery and puerperium. European Journal of Obstetrics, Gynaecology and Reproductive Biology. 34:1990;79-87.
45. Sibley D.R., Lefkowitz R.J. β-Adrenergic receptor-coupled adenylate cyclase. Molecular Neurobiology. 1:1987;121-154.
46. Spielberger, C.D., Gorsuch, R.L., Lushene, R.E., 1970. STAI Manual for the Sate-trait Anxiety Inventory ('Self-Evaluation Questionnaire'). Consulting Psychologists Press, Palo Alto, CA.
47. Spielberger, C.D., 1983. Manual for the State-Trait Anxiety Inventory, revised ed. Consulting Psychologists Press, Palo Alto, CA.
48. Stowell L.I., McIntosh C.J., Cooke R., Ellis P.M. Adrenoceptor and imipramine receptor binding during the menstrual cycle. Acta Psychiatrica Scandinavica. 78:1988;366-368.
49. Sulser F., Gillespie D.D., Mishra R., Manier D.H. Desensitization by antidepressants of central norepinephrine receptor systems coupled to adenylate cyclase. Annals of the New York Academy of Sciences. 430:1984;91-101.
50. Wagner H.R., Crutcher K.A., Davis J.N. Chronic estrogen treatment decreases β-adrenergic responses in rat cerebral cortex. Brain Research. 171:1979;147-151.
51. 2-adrenoceptors during the menstrual cycle. British Journal of Clinical Pharmacology. 37:1994;583-588.
52. Wood K., Whiting K., Coppen A. Lymphocyte beta-adrenergic receptor density of patients with recurrent affective illness. Journal of Affective Disorders. 10:1986;3-8.
53. Yonkers K.A., Gullion C., Williams A., Novak K., Rush A.J. Paroxetine as a treatment for premenstrual dysphoric disorder. Journal of Clinical Psychopharmacology. 16:1996;3-8.
54. Yonkers K.A. The association between premenstrual dysphoric disorder and other mood disorders. Journal of Clinical Psychiatry. 58:1997;1-7.
55. Zealley A.K., Aitken R.C.B. Measurement of mood. Proceedings of the Royal Society of London, Series B: Biological Sciences. 62:1969;993-996.
56. Zung W.W.K. A rating instrument for anxiety disorders. Psychosomatics. 12:1971;371-379.